Home › Stocks › NAMS

NewAmsterdam Pharma Co N.V. (NAMS): insider buying, hedge funds & Congress trades

NewAmsterdam Pharma Co N.V. (NAMS): 7 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Sep 17, 2025Topper James N
Director
660$23.70$15.6Kno history
Sep 10, 2025Topper James N
Director
1,260$24.99$31.5Kno history
Aug 13, 2025Topper James N
Director
471$23.98$11.3Kno history
Jun 26, 2025Topper James N
Director
3,780$18.37$69.5Kno history
Jun 18, 2025Topper James N
Director
8,584$19.50$167.4Kno history
Mar 28, 2025Topper James N
Director
1,135$22.49$25.5Kno history
Mar 6, 2025Topper James N
Director
4,005$21.02$84.2Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for NAMS

Free account. Know when insiders, famous funds or Congress trade it.

Start free